Drug Trial Radar · NCT02317705
Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer
Last checked: Nov 19, 2026Latest source record: Jun 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
Dec 2014
Primary completion
Nov 2015
Study completion Nov 2015
Sponsor
- Lead sponsor
- On Target Laboratories, LLCIndustry
- Sponsor type
- Industry
- Collaborators
- SynteractHCR
- First posted
- Dec 16, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being done to: * test the safety of OTL38 * see if OTL38 helps light up the cancer when viewed with the special camera system * test the safety of the special camera system for use along with OTL38 during surgery
Conditions
- Ovarian Cancer
Interventions
OTL38Drug
Near infrared camera imaging systemDevice
Near infrared camera imaging system
LaparotomyProcedure
primary surgical cytoreduction, interval debulking, or recurrent ovarian cancer surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensitivity of OTL38 in Detecting Folate Receptor-alpha Positive Ovarian Cancer During Surgery.Time frame: Day of Surgery (Day 1)
- Positive Predictive Value (PPV) of OTL38 in Detecting Folate Receptor-alpha Positive Ovarian Cancer During Surgery.Time frame: Day of Surgery (Day 1)
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
University of CA at Irvine Chao Cancer Center
Orange, California
Moffitt Cancer Center
Tampa, Florida
Mayo Clinic-Rochester
Rochester, Minnesota
University of Pennsylvania
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.